AU2002327093A1 - 1,2-dihydro-2-oxo-1,8-naphthyridine derivative - Google Patents

1,2-dihydro-2-oxo-1,8-naphthyridine derivative

Info

Publication number
AU2002327093A1
AU2002327093A1 AU2002327093A AU2002327093A AU2002327093A1 AU 2002327093 A1 AU2002327093 A1 AU 2002327093A1 AU 2002327093 A AU2002327093 A AU 2002327093A AU 2002327093 A AU2002327093 A AU 2002327093A AU 2002327093 A1 AU2002327093 A1 AU 2002327093A1
Authority
AU
Australia
Prior art keywords
dihydro
oxo
naphthyridine derivative
naphthyridine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002327093A
Other versions
AU2002327093B2 (en
Inventor
Hitoshi Ban
Masami Muraoka
Satoshi Ohnuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Dainippon Pharma Co Ltd filed Critical Sumitomo Dainippon Pharma Co Ltd
Priority claimed from PCT/JP2002/008266 external-priority patent/WO2003018581A1/en
Publication of AU2002327093A1 publication Critical patent/AU2002327093A1/en
Assigned to DAINIPPON SUMITOMO PHARMA CO., LTD. reassignment DAINIPPON SUMITOMO PHARMA CO., LTD. Request for Assignment Assignors: SUMITOMO PHARMACEUTICALS COMPANY
Application granted granted Critical
Publication of AU2002327093B2 publication Critical patent/AU2002327093B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002327093A 2001-08-23 2002-08-14 1,2-dihydro-2-oxo-1,8-naphthyridine derivative Ceased AU2002327093B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001-252673 2001-08-23
JP2001252673 2001-08-23
PCT/JP2002/008266 WO2003018581A1 (en) 2001-08-23 2002-08-14 1,2-dihydro-2-oxo-1,8-naphthyridine derivative

Publications (2)

Publication Number Publication Date
AU2002327093A1 true AU2002327093A1 (en) 2003-06-05
AU2002327093B2 AU2002327093B2 (en) 2007-08-16

Family

ID=19081111

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002327093A Ceased AU2002327093B2 (en) 2001-08-23 2002-08-14 1,2-dihydro-2-oxo-1,8-naphthyridine derivative

Country Status (9)

Country Link
US (1) US7067528B2 (en)
EP (1) EP1420017A4 (en)
JP (1) JP3787139B2 (en)
KR (1) KR20040036724A (en)
CN (1) CN1266150C (en)
AU (1) AU2002327093B2 (en)
CA (1) CA2456349A1 (en)
NZ (1) NZ531073A (en)
WO (1) WO2003018581A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005058316A1 (en) * 2003-12-17 2007-07-12 大日本住友製薬株式会社 Combinations and combinations
TW200605890A (en) * 2004-07-28 2006-02-16 Sankyo Co Pharmaceutical compositions for inhibiting arteriosclerosis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843957A (en) 1995-05-19 1998-12-01 Sumitomo Pharmaceuticals Company, Ltd. Naphthyridine derivatives
NZ308228A (en) * 1995-05-31 1999-11-29 Sumitomo Pharma Substituted 1,8-naphthyridine derivatives
JP2889864B2 (en) * 1996-02-28 1999-05-10 住友製薬株式会社 Crystalline vitamin D derivative
JPH1053576A (en) * 1996-06-07 1998-02-24 Eisai Co Ltd Polymorphic crystal of donepezil hydrochloride and its production
NZ335766A (en) * 1996-11-26 2000-11-24 Sumitomo Pharma Naphthyridine derivatives and use as acyl-CoA cholesterol acyl transferase(ACAT) inhibitor as treatment of hyperlipidemia
JP3317649B2 (en) * 1997-01-13 2002-08-26 日本ワイスレダリー株式会社 Carbapenem compounds in crystalline form
AU2547399A (en) * 1998-02-25 1999-09-15 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for producing the same
JPH11269194A (en) * 1998-03-19 1999-10-05 Nissin Food Prod Co Ltd Crystallization of para-toluoylglucosyl diflucortolone
US6420381B1 (en) 1998-08-11 2002-07-16 Sumitomo Pharmaceuticals Company, Limited Naphthyridine derivatives
JP2000212168A (en) * 1999-01-22 2000-08-02 Yamanouchi Pharmaceut Co Ltd New crystal of hexahydro-1,4-diazepine derivative salt hydrate

Similar Documents

Publication Publication Date Title
AU2002361992A1 (en) 1,4-dihydro-1,4-diphenylpyridine derivatives
IL160707A0 (en) 1, 8-naphthyridine derivatives as antidiabetics
AU2002349676A1 (en) 4-oxoquinoline derivatives
AU2002229976A1 (en) Imidazopyridines
AU2002352142A1 (en) Pyrazolopyridine derivatives
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
AU2002317759A1 (en) Ophthalmoscope
AU2002233706A1 (en) Pyridopyrimidine or naphthyridine derivative
AU2003300883A1 (en) Substituted 1-benzoyl-3-cyano-pyrrolo(1,2-a)quinolines
AU2003269949A1 (en) Substituted 1,4-pyrazine derivatives
AU2002363600A1 (en) Novel phenyl-propargylether derivatives
AU2002327093A1 (en) 1,2-dihydro-2-oxo-1,8-naphthyridine derivative
AU2002358715A1 (en) Tetrahydrobenzfluorene derivatives
AU2002233664A1 (en) Naphthyridine derivative
AU2001256791A1 (en) 5,6-trans-2-alkylvitamin d derivatives
AU2002361027A1 (en) Substituted 1,5-diaminopentan-3-ol compounds
AU2002355208A1 (en) 4-oxoimidazolidine-2-spiropiperidine derivative
AU2002255269B8 (en) 2-Iminopyrrolidine derivatives
AU2002249621A1 (en) 2-iminoimidazole derivative (2)
AU2002311321A1 (en) Novel norstatin derivative
AU2002335529A1 (en) Novel carbamoylpyrrolidone derivative
AU2002317000A1 (en) Morpholine-bridged pyrazolopyridine derivatives
AU2002354530A1 (en) 4-phenylpyran-2-one derivatives
AU2002325368A1 (en) Benzoylcyclohexenone derivatives
AU2002350425A1 (en) 6-phenyldihydropyrrolopyrimidinedione derivatives